Skip to main content

Advertisement

ADVERTISEMENT

News

News
11/15/2023
Travel, psychological factors, and financial burden on patients and their caregivers were the most common barriers to treatment for neovascular age-related macular degeneration, according to a review article published online ahead of print in...
Travel, psychological factors, and financial burden on patients and their caregivers were the most common barriers to treatment for neovascular age-related macular degeneration, according to a review article published online ahead of print in...
Travel, psychological factors,...
11/15/2023
First Report Managed Care
News
11/15/2023
“C difficile is a major cause of hospital-acquired diarrhea and represents an urgent concern due to the prevalence of antibiotic resistance and the rate of recurrent infections,” wrote Anthony Pannullo, Department of Microbiology and...
“C difficile is a major cause of hospital-acquired diarrhea and represents an urgent concern due to the prevalence of antibiotic resistance and the rate of recurrent infections,” wrote Anthony Pannullo, Department of Microbiology and...
“C difficile is a major cause of...
11/15/2023
First Report Managed Care

Advertisement

News
11/15/2023
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients...
11/15/2023
First Report Managed Care
News
11/14/2023
This research summary explores the experiences and perspectives of academic clinicians on increasing biosimilar adoption, emphasizing the need for education and systemic changes in pricing and reimbursement to improve acceptance among...
This research summary explores the experiences and perspectives of academic clinicians on increasing biosimilar adoption, emphasizing the need for education and systemic changes in pricing and reimbursement to improve acceptance among...
This research summary explores...
11/14/2023
First Report Managed Care
News
11/10/2023
Having long served as the model disorders for the development of gene therapy, hemophilia A (HA) and hemophilia B (HB) are currently benefitting from the role with the emergence of adeno-associated viral (AAV) vectors, according to a review...
Having long served as the model disorders for the development of gene therapy, hemophilia A (HA) and hemophilia B (HB) are currently benefitting from the role with the emergence of adeno-associated viral (AAV) vectors, according to a review...
Having long served as the model...
11/10/2023
First Report Managed Care

Advertisement

News
11/09/2023
“Switching to teriflunomide from existing DMTs in patients with relapsing MS resulted in a reduction in outpatient HCRU in this analysis of US claims data,” said researchers.
“Switching to teriflunomide from existing DMTs in patients with relapsing MS resulted in a reduction in outpatient HCRU in this analysis of US claims data,” said researchers.
“Switching to teriflunomide from...
11/09/2023
First Report Managed Care
News
11/09/2023
Fractional exhaled nitric oxide (FeNO) suppression testing (FeNOSuppT), as a screening tool before biologic therapy in difficult-to-control asthma cases, demonstrated cost savings of $4435 per patient over 1 year and was deemed cost-effective...
Fractional exhaled nitric oxide (FeNO) suppression testing (FeNOSuppT), as a screening tool before biologic therapy in difficult-to-control asthma cases, demonstrated cost savings of $4435 per patient over 1 year and was deemed cost-effective...
Fractional exhaled nitric oxide...
11/09/2023
First Report Managed Care
News
11/07/2023
This article highlights the global rise in allergic diseases and the significant economic burden they pose, focusing on the role of fungi in triggering allergic reactions and the need for further research to understand why type 2 immune...
This article highlights the global rise in allergic diseases and the significant economic burden they pose, focusing on the role of fungi in triggering allergic reactions and the need for further research to understand why type 2 immune...
This article highlights the...
11/07/2023
First Report Managed Care

Advertisement

News
11/07/2023
Dazdotuftide, a novel multi-target drug, offers promising potential for the treatment of diabetic retinopathy (DR), diabetic macular edema (DME), and age-related macular degeneration (AMD).
Dazdotuftide, a novel multi-target drug, offers promising potential for the treatment of diabetic retinopathy (DR), diabetic macular edema (DME), and age-related macular degeneration (AMD).
Dazdotuftide, a novel...
11/07/2023
First Report Managed Care
News
11/06/2023
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in...
11/06/2023
First Report Managed Care

Advertisement